Morgan Stanley analyst James Faucette lowered the firm’s price target on Corpay (CPAY) to $356 from $360 and keeps an Equal Weight rating on the shares following the Q2 report. The firm believes the company’s durable organic growth and capital allocation flexibility create an attractive entry point post the recent selloff.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CPAY:
- Crypto Currents: Trump signs executive order to allow crypto in 401(k) plans
- Corpay, Inc. Reports Balanced Q2 Earnings with Growth and Challenges
- Corpay price target lowered to $392 from $414 at Raymond James
- Corpay, Inc. Reports Strong Q2 Growth and Strategic Moves
- Corpay Inc: Positioned for Strong Growth with Strategic Acquisitions and Fintech Innovations